| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Glycobiology Program, Cancer Research Center, The Burnham Institute, La Jolla, California 92037 [J. Z., M. S., A. S., M. F., M. N. F.]; The Institute of Organ Transplants, Reconstructive Medicine and Tissue Engineering, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan [J. N.]; and Department of Urology, Akita University School of Medicine, Akita 010-8543, Japan [C. O.]
Endothelial carbohydrate binding proteins, E- and P-selectins, are thought to mediate sialylLewis A/X-dependent hematogenous cancer metastasis. We tested this hypothesisusing sialyl Lewis X-dependent B16 melanoma lung targeting andits inhibition with selectin ligand mimicry peptide, IELLQAR. In E/P-selectin doubly deficient mutant mice, sialyl Lewis X-expressing B16 melanoma cells colonized the lung, and IELLQAR inhibited this colonization. However, tumors grown in E/P-selectin-deficient mice were significantly smaller than those grown in wild-type mice. These results indicate that the IELLQAR peptide receptor expressed in the lung vasculature plays a major role in sialyl Lewis X-dependent cancer cells targeting to the lung.
This article has been cited by other articles:
![]() |
C. Ohyama, S. Kanto, K. Kato, O. Nakano, Y. Arai, T. Kato, S. Chen, M. N. Fukuda, and M. Fukuda Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides PNAS, October 15, 2002; 99(21): 13789 - 13794. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |